WHAT IS THE WORLD VACCINE CONGRESS? 

8 Conferences. 3 Days. 1 Event

At the World Vaccine Congress Washington in March 2016 more than 150 elite speakers and 500 specialists were in attendance, including big pharma, biotech, academics and government bodies.

In 2017, with 8 different conference streams at your disposal, you can make the most of your attendance by building a conference agenda that will perfectly answer your day-to-day challenges.

World Vaccine Congress - Cancer & ImmonotherapyWorld Vaccine Congress - Influenza & Respiratory

World Vaccine Congress - Emerging DiseasesWorld Vaccine Congress - Clinical Development

World Vaccine Congress - PartnershipsWorld Vaccine Congress - Bioprocess & Manufacturing

World Vaccine Congress - Veterinary

World Vaccine Congress - Immune Profiling

 

 

 

World Vaccine Congress Brochure

The opportunity

In 2016, over 650 vaccine experts from top pharmaceutical and biotechnology companies worldwide attended the event.

 

With the exhibition being sold out in 2016, we highly recommend partners to register their interest early before the next exhibition and sponsorship opportunities are gone. Indeed, 65% of the 2017 exhibition is already sold out!

 

No matter where your interest lies, we have content, networking and potential partners for you.

 

DOWNLOAD PROSPECTUS

Our Scientific Advisory Board

 

Dr Gregory A. Poland, Director of Mayo Vaccine Research Group, Mayo Clinic and Foundation

Dr Gregory A. Poland
Director of Mayo Vaccine Research Group
Mayo Clinic 

Dr Cyril Gay, Senior National Program Leader, A.R.S. National Programs

Dr Cyril Gay
Senior National Program Leader, Office of National Programs
USDA

Dr George Siber, CSO of ClearPath Vaccines & Scientific Advisory Board of Genocea, ClearPath Vaccines

Dr George Siber
CSO of ClearPath Vaccines & Chair of Scientific Advisory Board, Genocea Bioscience Inc

 

Dr. Leonard Friedland, VP, Scientific Affairs and Public Health Vaccines, North America, GSK

Dr. Leonard Friedland
VP, Scientific Affairs and Public Health Vaccines, North America
GSK

Dr Peter Hotez, President of the Sabin Vaccine Institute and Dean of National School of Tropical Medicine, Baylor College of Medicine

Dr Peter Hotez
President of the Sabin Vaccine Institute and Dean of National School of Tropical Medicine, Baylor College of Medicine

Prof Stanley Plotkin, Emeritus Professor, University of Pennsylvania School of Medicine

Prof Stanley Plotkin
Emeritus Professor
University of Pennsylvania School of Medicine

Penny Heaton 
Director of Vaccine Development, Global Health Program
Bill and Melinda Gates Foundation

 

 

VIEW THE 2017 SPEAKER LINE UP

  •  

     

    Excellent attendance from a wide representative of the vaccine industry, especially pharma, so excellent networking/partnership opportunities, great speakers

     

    Group Leader / Department Coordinator,
    QIMR Berghofer Medical Research Institute

     

     

  •  

     

     

     

    A “never miss” conference on my annual list of key scientific conferences.

    It is a unique meeting where scientists, biotech and pharma representatives, and business leaders discuss and review critical scientific advances, and professionally network.

     

    Dr Gregory A. Poland
    Mayo Clinic